TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) Investor Investigation Over Potential Wrongdoing Announced

  • Investors, who purchased shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
ZIOPHARM Oncology Inc.
Security
NASDAQ: ZIOP

Summary

An investigation on behalf of investors in shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) was announced over potential breaches of fiduciary duties by certain officers and directors at ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP.

The investigation by a law firm concerns whether certain ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Boston, MA based ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. Shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) declined to as low as $2.23 per share on August 6, 2018.

Start Monitoring Your Investments